These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29371234)

  • 41. Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
    Pinckney A; Rigby MR; Keyes-Elstein L; Soppe CL; Nepom GT; Ehlers MR
    Clin Ther; 2016 Jun; 38(6):1327-1339. PubMed ID: 27209482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Six-Month Effectiveness of Advanced
    Tornese G; Buzzurro F; Carletti C; Faleschini E; Barbi E
    Front Endocrinol (Lausanne); 2021; 12():766314. PubMed ID: 34858339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes and High-Risk Glycemic Control: A Randomized Controlled Trial.
    Boucher SE; Gray AR; Wiltshire EJ; de Bock MI; Galland BC; Tomlinson PA; Rayns JA; MacKenzie KE; Chan H; Rose S; Wheeler BJ
    Diabetes Care; 2020 Oct; 43(10):2388-2395. PubMed ID: 32788281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-sectional and longitudinal relationships of body mass index with glycemic control in children and adolescents with type 1 diabetes mellitus.
    Nansel TR; Lipsky LM; Iannotti RJ
    Diabetes Res Clin Pract; 2013 Apr; 100(1):126-32. PubMed ID: 23339757
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
    Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
    Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
    Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
    Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Timing of CGM initiation in pediatric diabetes: The CGM TIME Trial.
    Lawson ML; Verbeeten KC; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Chan J; Tang K
    Pediatr Diabetes; 2021 Mar; 22(2):279-287. PubMed ID: 33098212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter.
    Schnell O; Klausmann G; Gutschek B; Garcia-Verdugo RM; Hummel M
    J Diabetes Sci Technol; 2017 Nov; 11(6):1218-1225. PubMed ID: 28443343
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of nutrient intake with glycemic control in youth with type 1 diabetes: differences by insulin regimen.
    Katz ML; Mehta S; Nansel T; Quinn H; Lipsky LM; Laffel LM
    Diabetes Technol Ther; 2014 Aug; 16(8):512-8. PubMed ID: 24766666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
    Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
    An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
    JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes patients switching to continuous subcutaneous insulin infusion.
    Crenier L
    Diabetes Technol Ther; 2014 Apr; 16(4):247-54. PubMed ID: 24237387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stabilization of glycemic control and improved quality of life using a shared medical appointment model in adolescents with type 1 diabetes in suboptimal control.
    Floyd BD; Block JM; Buckingham BB; Ly T; Foster N; Wright R; Mueller CL; Hood KK; Shah AC
    Pediatr Diabetes; 2017 May; 18(3):204-212. PubMed ID: 26919322
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
    Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
    Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
    Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effects of Risk Behaviors and Orthorexic Behavior on Glycemic Control in Adolescents with Type 1 Diabetes.
    Taş D; Mengen E; Kocaay P; Uçaktürk SA
    J Clin Res Pediatr Endocrinol; 2020 Sep; 12(3):233-240. PubMed ID: 31722516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ; Gunton JE; Hawthorne W; Payk M; Anderson P; Donath S; Loudovaris T; Ward GM; Kay TW; OʼConnell PJ
    Transplantation; 2017 Jun; 101(6):1268-1275. PubMed ID: 27490410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carbohydrate counting with an automated bolus calculator helps to improve glycaemic control in children with type 1 diabetes using multiple daily injection therapy: an 18-month observational study.
    Rabbone I; Scaramuzza AE; Ignaccolo MG; Tinti D; Sicignano S; Redaelli F; De Angelis L; Bosetti A; Zuccotti GV; Cerutti F
    Diabetes Res Clin Pract; 2014 Mar; 103(3):388-94. PubMed ID: 24447811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
    Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
    BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.